Mydecine Innovations Group Provides Corporate Update
03 avr. 2023 06h00 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering...
Biopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partners
23 mars 2023 08h46 HE
|
The Insight Partners
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biopharmaceuticals Market Size, Share, Trends, Growth and Report Forecasts to 2028 - COVID-19 Impact and Global...
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
07 mars 2023 08h00 HE
|
Certara
PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 22, which includes new...
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
01 févr. 2023 16h30 HE
|
Certara
PRINCETON, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and...
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
07 nov. 2022 08h00 HE
|
Certara
PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and...
Certara to Participate in Upcoming Investor Conferences
02 nov. 2022 17h00 HE
|
Certara
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
13 oct. 2022 07h45 HE
|
Certara
PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Mice Model Market is expected to generate a revenue of USD 2464.65 Million by 2027, Globally, at 7.65% CAGR: Verified Market Research®
13 sept. 2022 11h15 HE
|
Verified Market Research
Jersey City, New Jersey, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Mice Model Market” By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice,...
Certara Appoints Eran Broshy as New Independent Board Member
13 juil. 2022 08h00 HE
|
Certara
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective...
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
20 avr. 2022 08h00 HE
|
Certara
PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of...